Subscribe by email, free
Your daily briefing for podcasting and on-demand

PeerView Internal Medicine CME/CNE/CPE Video Podcast - deep links to episodes

Updated UTC · this page updates every two hours

These are magic links to individual episodes for PeerView Internal Medicine CME/CNE/CPE Video Podcast, provided to help you share episode links for this podcast that work on any device.

These links work on everything: they open the episode on Apple Podcasts on an iOS device like an iPhone; will open the episode on the Google Podcasts player on an Android device; and will open a web player on any other device. Right-click a link to copy the link address.

Just want to link to the podcast? Use this magic link: Listen to PeerView Internal Medicine CME/CNE/CPE Video Podcast

Jan 28 2022:Erika Hamilton, MD - Expanding Treatment Options in ER+/HER2- Breast Cancer: Expert Perspectives on the Rapidly Emerging Role of SERDs, SERMs, and SERCAs, and the Practical Considerations of Leveraging Established and Innovative Therapies
Direct links:
Jan 26 2022:Nathan H. Fowler, MD - A Better Blend for Follicular Lymphoma: How Targeted, Epigenetic, and Immune Therapies Are Changing Patient Care
Direct links:
Jan 26 2022:Neal K. Lakdawala, MD - Making New Strides in Hypertrophic Cardiomyopathy: The Latest Guidelines, Science, and Strategies for Early Diagnosis and Tailored Treatment
Direct links:
Jan 24 2022:Stephen R. Broderick, MD, MPHS/Heather A. Wakelee, MD - Has Immunotherapy Brought Us to an Inflection Point in the Multimodal Management of Stage I-III NSCLC? Dissecting the Data and Instituting Multidisciplinary Alliances to Improve Outcomes in Early-Stage Disease
Direct links:
Jan 20 2022:Christopher Baugh, MD, MBA & Mark M. Awad, MD, PhD - Maintaining Vigilance to Mitigate Cancer Immunotherapy-Related Toxicities in the Emergency Department: Be Aware, Stay Alert, and Change Your Practice
Direct links:
Jan 20 2022:John C. Byrd, MD - Customizing Care in CLL With BTK Inhibitors: Evidence and Applications for Therapy Selection, Sequencing, and Safety Management
Direct links:
Jan 20 2022:Bradley S. Miller, MD, PhD - Advances in Pediatric Growth Hormone Therapy: Visualizing the Impact on Individualized Care
Direct links:
Jan 12 2022:John G. Gribben, MD, DSc, FRCP, FRCPath, FMedSci - Achieving Innovation in CLL Care: Evidence-Informed Choices With Targeted Options and Next Steps in Disease Management
Direct links:
Jan 11 2022:Jennifer Wargo, MD, MMSc - Leveraging Neoadjuvant and Adjuvant Immunotherapy to Break Through the Outcomes Plateau, Prevent Recurrences, and Improve Curability in Early-Stage Cancers
Direct links:
Jan 11 2022:Lenard A. Adler, MD / Oren Mason, MD - Overcoming Challenges in the Recognition and Management of Adult ADHD in Primary Care: Optimizing Outcomes to Reduce Disease Burden and Improve Quality of Life
Direct links:
Jan 11 2022:Robert Dreicer, MD, MS, MACP, FASCO/Pedro C. Barata, MD, MSc - Personalizing and Advancing Modern Treatment Approaches to Prostate Cancer
Direct links:
Jan 10 2022:Emma Guttman-Yassky, MD, PhD - Expert Insights From Around the Globe on Tailoring Treatment for Patients With Atopic Dermatitis
Direct links:
Jan 6 2022:David Malebranche, MD, MPH - Parallel Perspectives: A Unique Look at HIV Treatment Decisions From the Provider and the Patient
Direct links:
Jan 6 2022:Sumanta Kumar Pal, MD, FASCO - Selecting and Sequencing Targeted and Immunotherapy Regimens for RCC: How Will the Latest Evidence Impact Treatment Decisions for My Patients?
Direct links:
Dec 20 2021:Amit Singal, MD, MS - Harmonizing HCC Care With a Multidisciplinary Ensemble: Guidance for the Era of Novel Locoregional, Multimodal, and Systemic Strategies
Direct links:
Dec 20 2021:David R. Jones, MD - Adjuvant EGFR-Targeted Therapy as a Game Changer: How to Implement New Standards of Care in Multimodal Management of Stage I-III EGFR-Mutated NSCLC
Direct links:
Dec 16 2021:Javid Moslehi, MD - Improving the Detection and Management of Cardiac Immune-Related Adverse Events in Patients With Cancer Is a Must: Are You Prepared?
Direct links:
Dec 16 2021:Joyce O’Shaughnessy, MD - Raising the Bar in HR+/HER2- Early Breast Cancer: Multidisciplinary Strategies for Integrating the CDK4 and 6 Inhibitors
Direct links:
Dec 16 2021:Steven E. Carsons, MD - Addressing Unmet Needs in the Treatment of Primary Sjögren's Syndrome: Expert Insight on the Therapeutic Potential for CD40 Pathway Blockade
Direct links:
Dec 10 2021:Domenica M. Rubino, MD & Donna H. Ryan, MD, FTOS -Gut Feeling: The Increasing Importance of GLP-1–Based Therapies for Personalized Obesity Management
Direct links:
Dec 9 2021:Nirav Shah, MD, MS - Visualizing Progress With BTK Inhibitors: An Animated Journey Through the Mechanisms of Covalent and Noncovalent Options
Direct links:
Dec 9 2021:R. Sharon Chinthrajah, MD - Fulfilling Unmet Treatment Needs for Patients With IgE-Mediated Food Allergies: An Animated Exploration of Emerging Targeted Therapy
Direct links:
Dec 8 2021:Erik P. Sulman, MD, PhD - Implementing Synergistic Multimodal Approaches With Tumor Treating Fields to Extend Survival in Aggressive Cancers
Direct links:
Dec 8 2021:Lynette M. Sholl, MD - Time for Even More Precision in Testing and Treatment of EGFR-Mutated NSCLC: Refining and Expanding Best Practices in Advanced and Early-Stage Disease Settings
Direct links:
Dec 8 2021:Benjamin M. Greenberg, MD, MHS & Professor Anthony Traboulsee, MD - Bruton Tyrosine Kinase Inhibitors for MS: Progress in the Development of an Emerging Therapeutic Approach
Direct links:
Dec 8 2021:Donna E. Sweet, MD, AAHIVS, MACP - The HIV Prevention–Certified Provider Program: A Training and Certificate Program Designed to Improve Competencies and Expand the HIV Prevention Workforce
Direct links:
Nov 29 2021:Richard Elion, MD / Rupa R. Patel, MD, MPH, DTM&H - PrEP for All Ages: A Comprehensive Look at Employing HIV Prevention Strategies Across All Age Groups
Direct links:
Nov 29 2021:Jonathan W. Goldman, MD - Translating Science, Transforming Practice, and Making Headway Toward Better Outcomes in SCLC: Immunotherapy Has Changed the Game, but Where Do We Go Next?
Direct links:
Nov 26 2021:Carl Regillo, MD - Clinical Colloquia in Retinal Disease: Updating Evidence-Based, Patient-Centered Care for Diabetic Retinopathy
Direct links:
Nov 22 2021:Bruce Cree, MD, PhD, MAS - Exploring the Convergence of Advances in S1P Receptor Modulation With Progress in Understanding Brain Atrophy and Cognition Measures in Multiple Sclerosis
Direct links:
Nov 19 2021:Jonathan A. Bernstein, MD - Visualizing Progress in the Management of Chronic Spontaneous Urticaria: Harnessing the Clinical Potential of New and Novel Therapies to Address Unmet Patient Needs
Direct links:
Nov 16 2021:Prof Eric Van Cutsem, MD, PhD - Putting a Personalized Colorectal Cancer Treatment Algorithm Into Practice: Navigating Practicalities in the Era of Molecularly Defined Care
Direct links:
Nov 12 2021:Timothy Berger, MD - Changing the Game for Patients With Prurigo Nodularis: Best Practices to Achieve Treatment Goals and Improve Quality of Life
Direct links:
Nov 9 2021:Andrew J. Wagner, MD, PhD - Overcoming the Challenges of Diverse TGCT Presentations: Diagnostic and Treatment Principles for the Multidisciplinary Team
Direct links:
Nov 5 2021:Kurt A. Schalper, MD, PhD - Evolving Standards in Biomarker Testing, Scoring, and Results Interpretation Driven by the Broadening Role of Cancer Immunotherapy
Direct links:
Nov 3 2021:Lisa A. Beck, MD - Integrating the Latest Evidence Into Practice: Expert Insights on Targeted Biologic Therapy for Pediatric and Adult Patients With Moderate to Severe Atopic Dermatitis
Direct links:
Oct 25 2021:Philip J. Mease, MD, MACR - Improving the Recognition and Effective Management of Axial Spondyloarthritis: Practical Guidance for the Primary Care Provider
Direct links:
Oct 19 2021:Srdan Verstovsek, MD, PhD / Ruben A. Mesa, MD, FACP - Understanding the Clinical Spectrum of Myelofibrosis: Expert Perspectives on Molecular Biology, JAK Inhibitors, and Emerging Therapeutics
Direct links:
Oct 19 2021:Melissa L. Johnson, MD - Harnessing the Potential of HER2-, HER3-, and TROP2-Targeted Therapies to Address Unmet Needs in Advanced NSCLC
Direct links:
Oct 19 2021:Daniel Jacoby, MD - Easing the Burden of Hypertrophic Cardiomyopathy: Progress in Understanding and Addressing Its Pathophysiology
Direct links:
Oct 19 2021:Nicole Lamanna, MD / Jennifer Woyach, MD - Seizing the Day With BTK Inhibitors in CLL: Evidence-Informed Therapy Selection, Safety, and Sequential Care
Direct links:
Oct 14 2021:Anthony R. Mato, MD, MSCE - Interprofessional Perspectives on Safety Management With Targeted Therapy for B-Cell Malignancies
Direct links:
Oct 13 2021:Sagar Lonial, MD, FACP - Breaking Therapeutic Barriers in RRMM: Team-Based Solutions for Integrating Novel Antibody Platforms and Improving Myeloma Care
Direct links:
Oct 12 2021:Jared Weiss, MD - Raising the Bar for Patient Outcomes With Transcription Inhibition and Other New Options in the Treatment Arsenal for SCLC: Rationale, Mechanisms of Action, Latest Data, and Practicalities of Clinical Use in Oncology Practice
Direct links:
Oct 12 2021:Milind Javle, MD - Taking Action in Advanced Biliary Cancers: Expert Insights on Integrating Newly Available and Innovative Therapeutics to Deliver Precision-Based Care
Direct links:
Oct 11 2021:Kenneth R. Cooke, MD - Collaborative Strategies for Managing VOD/SOS: Interprofessional Insights on Advances in Diagnosis, Severity Grading, and Treatment
Direct links:
Oct 11 2021:Anthony R. Mato, MD, MSCE - The Next Building Block for B-Cell Cancer Care: Exploring Personalized Treatment With Emerging BTK Inhibitor Options in CLL/SLL and MCL
Direct links:
Oct 8 2021:R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA/ Kathryn Maples, PharmD, BCOP / Tim J. Peterson, PharmD, BCOP -Making Sense of the New World of Myeloma Care: Pharmacy Perspectives on Novel Antibodies and BCMA CAR-T Therapy
Direct links:
Oct 6 2021:Stephen V. Liu, MD - Maximizing the Potential of Immunotherapy in Multimodal Management of Unresectable Stage III NSCLC: Collaboration Is Crucial, Patient Selection Is Paramount, Close Monitoring Is Critical
Direct links:
Sep 30 2021:April W. Armstrong, MD, MPH / Kenneth B. Gordon, MD - Taking Aim at the TYK2 Pathway in Psoriasis: Addressing Unmet Treatment and Patient Needs With an Innovative Therapeutic Approach
Direct links:
Sep 29 2021:Jamie E. Chaft, MD - Marking New Milestones With Immunotherapy in Locally Advanced and Early Lung Cancer: Latest Data Informing Best Practices for Multimodal Management of Stage I-III NSCLC
Direct links:
Sep 29 2021:Stephen V. Liu, MD - Tracking All the Targets in Genomically Altered NSCLC: Everything You Need to Know About Biomarker Testing and Treatment
Direct links:
Sep 28 2021:Nina Shah, MD - Innovation at Warp Speed for Multiple Myeloma: Tumor Board Insights on State-of-the-Art Care
Direct links:
Sep 20 2021:Peter A. Lio, MD - Overcoming Challenges in the Management of Moderate to Severe Atopic Dermatitis: Practical Strategies for Selecting Treatment for Pediatric and Adult Patients
Direct links:
Sep 13 2021:Ian W. Flinn, MD, PhD - Visualizing the Present and Future of CLL: How Innovative Therapies and State-of-the-Art Combinations Are Transforming Patient Care
Direct links:
Aug 31 2021:Laura J. Zitella, MS, RN, ACNP-BC, AOCN - Taking the Fight to AML: Oncology Nurse Perspectives, Principles, and Practice in an Era of Innovative Therapies
Direct links:
Aug 17 2021:Alok A. Khorana, MD, FACP, FASCO / Robert D. McBane, II, MD - Reducing the Global Burden of Cancer-Associated VTE: Applying Guideline-Concordant, Evidence-Based Care and Shared Decision-Making Strategies to Improve Patient Outcomes
Direct links:
Aug 6 2021:Donna H. Ryan, MD, FTOS -Demystifying the Role of Incretin-Based Weight-Loss Pharmacotherapy: A Patient-Centered Approach to Overcoming Barriers and Addressing Underlying Causes of Obesity
Direct links:
Aug 6 2021:Nicola Gökbuget, MD - Achieving Therapeutic Innovation in ALL: Insights on Modern Asparaginase Compounds in Pediatric, AYA, and Adult Patients
Direct links:
Aug 5 2021:Charles Vega, MD, FAAFP - Examining Novel Approaches to Improve the Management of Influenza: An Animated Exploration
Direct links:
Aug 5 2021:R. Robert Auger, MD, FAASM, FAPA, DABPN - The Dawn of a New Era: Recent Advances in the Pharmacologic Management of Idiopathic Hypersomnia
Direct links:
Aug 5 2021:Jason J. Luke, MD, FACP / Geoffrey T. Gibney, MD - Building Better Models for Melanoma Care: Continued Progress With Immunotherapy in Resectable and Unresectable Disease
Direct links:
Jul 30 2021:James R. Gavin III, MD, PhD - The Contemporary Use of GLP-1 RAs to Individualize Therapy in T2DM: Candid Conversations on Glycemic and Nonglycemic Effects
Direct links:
Jul 30 2021:Sara M. Tolaney, MD, MPH - Evaluating the Evidence and Parsing the Practicalities of Therapeutic Choices in Advanced and Early HR+ Breast Cancer: Expert Perspectives on CDK4 and 6 Inhibitors and Other Novel Agents
Direct links:
Jul 30 2021:Suzanne Lentzsch, MD, PhD - A New Treatment Era for Light Chain Amyloidosis: Interprofessional Lessons From a Center of Excellence
Direct links:
Jul 26 2021:Bruce R. Korf, MD, PhD / Nicole J. Ullrich, MD, PhD, MMSci - Translating Science to Transform Clinical Practice: How MEK Inhibitors Are Changing the Treatment Landscape of NF1 and NF1-Associated Tumors
Direct links:
Jul 26 2021:Vanita R. Aroda, MD - Determining Which Patients Will Benefit From GLP-1 RAs: Applying Guidelines and Evidence to Individualize Treatment Decisions in T2DM
Direct links:
Jul 22 2021:Christopher D. Still, DO, FACP, FTOS / Alan C. Wittgrove, MD, FASMBS, FACS - Going With Your Gut: Targeting Long-Term Weight Loss With Current and Emerging Incretin-Based Pharmacotherapy
Direct links:
Jul 21 2021:Jacob Sands, MD - Making the Most of Treatment Advances in SCLC: New Standards, Practicalities of Care, and Hope on the Horizon
Direct links:
Jul 21 2021:Joyce O’Shaughnessy, MD - Expanding the Benefits of Checkpoint Inhibitors and Targeted Agents in the Treatment Arsenal for Triple-Negative Breast Cancer
Direct links:
Jul 16 2021:Sara Hurvitz, MD - Making Progress in Early and Advanced HER2-Positive Breast Cancer: Leveraging HER2-Targeted Therapies and Modern Care Principles to Improve Clinical Outcomes and Health Equity
Direct links:
Jul 15 2021:William G. Wierda, MD, PhD - New Standards for CLL Care With BTK Inhibitors: Using Evidence to Make Personalized Treatment Choices
Direct links:
Jul 8 2021:April W. Armstrong, MD, MPH - Beyond TNF Inhibitors: Latest and Emerging Evidence on Novel Cytokine-Modulating Strategies in the Treatment of Moderate to Severe Psoriasis
Direct links:
Jul 8 2021:Karl D. Lewis, MD - Innovative Immunotherapy in Advanced Basal Cell Carcinoma: Evolving Science, Key Clinical Evidence, and Implications for Multidisciplinary Management
Direct links:
Jul 7 2021:James T. Rosenbaum, MD - Teaming Up to Overcome Challenges in the Diagnosis and Management of Noninfectious Uveitis: Enhancing Multidisciplinary Care in the Biologic Therapy Era
Direct links:
Jun 28 2021:James A. Underberg, MD, MS, FACPM, FACP, FNYAM, FASPC, FNLA - Management of Hyperlipidemia in the Family Medicine Setting: Diagnosis, Management, and the Role of Emerging Lipid-Lowering Therapies
Direct links:
Jun 28 2021:Sara M. Tinsley, PhD, APRN, AOCN - Therapeutic Advancements in Myelodysplastic Syndromes: Bridging the Gap Between Patient Safety and Quality Care Through the Latest Science and Evidence-Based Learning in Nursing Practice
Direct links:
Jun 25 2021:Andrew Blauvelt, MD, MBA - Addressing the Unmet Needs of Patients With Moderate to Severe Psoriasis: A Visual Exploration of Disease Pathogenesis and the Clinical Potential of Targeting the TYK2 Pathway as a Novel Nonbiologic Oral Therapeutic Option
Direct links:
Jun 25 2021:Steven W. Pipe, MD - Envisioning the Future of Emerging Nonfactor Therapies in Hemophilia A and B: The Art and Science of RNA Interference
Direct links:
Jun 25 2021:George L. Bakris, MD - Recognizing and Treating Hyperkalemia in Patients With Heart Failure and/or Chronic Kidney Disease: An Update for Hospitalists
Direct links:
Jun 24 2021:Shanu Modi, MD - Navigating Shifts in the Treatment Landscape for Metastatic HER2-Positive Breast Cancer: Can New HER2-Targeted Therapies Address Unmet Needs and Offer Better Options for Challenging Patient Populations?
Direct links:
Jun 24 2021:Jonathan I. Silverberg, MD, PhD, MPH / Eric Simpson, MD, MCR - Advancing Care for People Living With Moderate to Severe Atopic Dermatitis: The Future Looks Clear
Direct links:
Jun 22 2021:Brendon M. Stiles, MD - Immunotherapy as a Game-Changer in Multimodal Management of Locally Advanced and Earlier Stages of Lung Cancer
Direct links:
Jun 22 2021:Lesley Camille Ballance, MSN, FNP-BC / Amy Goodrich, CRNP / Jill Lozensky, RN, BSN, OCN - Changing Times in DLBCL: Oncology Nurse Insight on the Practicalities of Antibody Therapy
Direct links:
Jun 22 2021:Elizabeth A. Raetz, MD / Rachel Rau, MD - Meeting Therapeutic Challenges in Pediatric ALL: Expert Perspectives on the Use of Asparaginase Compounds
Direct links:
Jun 22 2021:Richard K. Bogan, MD, FCCP, FAASM - The Evolving Role of Oxybate Agents in the Management of Narcolepsy: A Visual Exploration of Individualized Care
Direct links:
Jun 21 2021:Matthew D. Galsky, MD - The Therapeutic Transformation of Bladder Cancer: Understanding Immune-, Targeted-, and Antibody-Based Models for Patient Care
Direct links:
Jun 21 2021:Suresh S. Ramalingam, MD, FACP, FASCO / Arjun Balar, MD / Yelena Janjigian, MD - Revisiting PD-L1 as an Immunotherapy Biomarker Across the Cancer Spectrum: Current and Emerging Standards of Testing, Scoring, and Assay Interpretation
Direct links:
Jun 18 2021:Amy Goodrich, CRNP - Making Modern Treatment Choices in CLL: Oncology Nurse Insights on the Patient Journey and the New Era of Care
Direct links:
Jun 18 2021:Evan J. Lipson, MD - Analyzing the Pros and Cons of Standard and Alternative Dosing Regimens of Immunotherapies and Combinations in Modern Oncology Practice
Direct links:
Jun 17 2021:Brett Elicker, MD - The Importance of Early Recognition of Interstitial Lung Diseases: Practical Strategies for the Radiologist
Direct links:
Jun 16 2021:Joseph D. Khoury, MD, FCAP - Visualizing Progress for TP53-Mutant AML: A Pathology-Guided Journey Through Diagnostic Principles and Modern Treatment
Direct links:
Jun 15 2021:Susana Banerjee, MBBS, MA, FRCP, PhD / William J. Gradishar, MD, FASCO, FACP / Maha Hussain, MD, FACP, FASCO
Direct links:
Jun 11 2021:Kurt A. Schalper, MD, PhD / Shanu Modi, MD - HER2 and HER3 Alterations as Therapeutic Targets of Increasing Significance in Solid Tumors: Implications for Pathology and Oncology Practice
Direct links:
Jun 9 2021:Benjamin W. Friedman, MD, MS, FAAEM, FACEP, FAHS - A New Era of Migraine Management: Recent Updates on Recognition, Acute Treatment, and Prevention for Emergency Physicians
Direct links:
Jun 7 2021:Crystal M. Proud, MD - Data-Based Updates: Practical Application of Recent Evidence on Disease-Modifying Therapies for SMA
Direct links:
Jun 4 2021:Michael R. Bishop, MD - Betting on CAR-T Cell Therapy: Expert Perspectives on Effective Integration Strategies and Achieving Improved Outcomes Across Hematologic Cancers
Direct links:
Jun 2 2021:Karl E. Anderson, MD - Acute Hepatic Porphyria: Disease Diagnosis and Revelations Regarding the Role of siRNA Therapy
Direct links:
Jun 1 2021:Dara L. Aisner, MD, PhD / Joshua Bauml, MD / Paul A. VanderLaan, MD, PhD - Precision Decisions in Genomic Testing and Targeted Treatment of NSCLC
Direct links:
May 28 2021:Naval Daver, MD - Optimizing Care for High-Risk Myeloid Cancers: Interprofessional Team Insights From a Center of Excellence
Direct links:
May 21 2021:Brett King, MD, PhD - Addressing the Unmet Needs of Patients With Moderate to Severe Alopecia Areata: A Visual Exploration of Disease Pathogenesis and the Clinical Potential of Novel Therapeutic Options
Direct links:
May 20 2021:Hossein Borghaei, DO, MS / Sanjay Mukhopadhyay, MD / Jonathan A. Nowak, MD, PhD - The Nuances of Immunotherapy Biomarker Testing in Solid Tumors: Unraveling Complexities and Overcoming Challenges to Improve Outcomes
Direct links:
May 18 2021:April W. Armstrong, MD, MPH - Targeting the Burden of Moderate to Severe Psoriasis: A Visual Exploration of the Role of IL-17 Inhibitors in Improving Patient Care and Quality of Life
Direct links:
May 14 2021:John M. Pagel, MD, PhD / Ian W. Flinn, MD, Ph - DConversations on the New Wave of Innovative Therapy in Follicular Lymphoma: Implications for Personalized Medicine
Direct links:
May 11 2021:Jay H. Shubrook, DO, FAAFP, FACOFP - Partnering With Peers and Patients: Achieving T2DM Treatment Goals With GLP-1 RA Therapy
Direct links:
May 10 2021:Alexander (Ander) Cohen, MB BS (Hons), MSc, MD, FRACP, FESC - New Insights: How Does Real-World Evidence Influence VTE Management? A Visual Exploration of Real-World Studies of DOACs
Direct links:
Apr 30 2021:Minetta C. Liu, MD - Innovative Blood-Based Screening in Cancer Care: State of the Science and Future Opportunities for Accelerating Cancer Diagnoses
Direct links:
Apr 30 2021:Roy S. Herbst, MD, PhD & Lecia V. Sequist, MD, MPH - New Milestones and Changing Standards of Care in EGFR-Mutated NSCLC: Expanding the Benefits of Genomic Testing and EGFR-Targeted Therapy to Early-Stage Lung Cancer
Direct links:
Apr 22 2021:Khaldoun G. Tarakji, MD, MPH - Adopting Telemedicine and Digital Tools for Nonvalvular Atrial Fibrillation Management and Stroke Prevention
Direct links:
Apr 21 2021:Toni K. Choueiri, MD - RCC MasterClass and Clinical Consult: Remodeling the Treatment Algorithm With Novel Immune and Targeted Therapies
Direct links:
Apr 13 2021:Professor Thomas Powles, MBBS, MRCP, MD - Examining the State of the Science on New Therapies in Bladder Cancer: Perspectives on the Latest Developments Across the Disease Continuum
Direct links:
Apr 8 2021:Corey Cutler, MD, MPH, FRCP(C) & Miguel-Angel Perales, MD - New Perspectives in Acute and Chronic GVHD: Challenges and Opportunities for Improving Prophylaxis and Treatment With Novel Therapeutics
Direct links:
Apr 5 2021:Philip J. Mease, MD, MACR - IL-17 Inhibitors in Nonradiographic Axial Spondyloarthritis: Expert Insight on Clinical Decision-Making in an Expanding Therapeutic Landscape
Direct links:
Apr 2 2021:Robert Dreicer, MD, MS, MACP, FASCO - Making the Right Moves in the Evolving Prostate Cancer Therapeutic Landscape: Expert Guidance on Treatment Sequencing and Selection for Effective Management Across the Disease Continuum
Direct links:
Mar 31 2021:Gail J. Roboz, MD / James M. Foran, MD, FRCPC - Charting Progress in AML Care: A Clinical CaseBook on the Intersection of Novel Therapy and Allogeneic HCT
Direct links:
Mar 26 2021:Ruben A. Mesa, MD, FACP / Jeanne M. Palmer, MD - How to Manage JAK Inhibition in Patients Undergoing HCT: Applying the Latest Clinical Evidence to Improve Patient Outcomes in Myelofibrosis
Direct links:
Mar 22 2021:Jason J. Luke, MD, FACP - Expanding the Benefits of Immuno-Oncology to More Patients With Solid Tumors Through Novel Rational Targets and Combinations
Direct links:
Mar 19 2021:Rishi P. Singh, MD - Taking an Individualized Approach to Neovascular Age-Related Macular Degeneration: Examining the Evidence to Improve Patient Outcomes
Direct links:
Mar 17 2021:Richard S. Finn, MD - How I Think, How I Treat: Remodeling the HCC Treatment Algorithm With New and Emerging Monotherapy, Combination, and Multimodal Approaches
Direct links:
Mar 10 2021:Stephen V. Liu, MD - Changing the Game for Patients With ES-SCLC Through Multidisciplinary Collaboration: Best Practices to Optimize Immunotherapy-Based Approaches and Improve Patient Outcomes
Direct links:
Mar 8 2021:Robert Z. Orlowski, MD, PhD / Nina Shah, MD - The Multiple Myeloma Workshop: Exploring the Convergence of Novel Therapeutic Platforms, Cell Therapy, and ASCT
Direct links:
Mar 3 2021:Reynold A. Panettieri, Jr., MD - Improving Adherence to Evidence-Based Guidelines for the Diagnosis and Management of COPD: Practical Strategies for the Healthcare Team to Optimize Patient Care
Direct links:
Mar 1 2021:Axel Grothey, MD - Taking Aim at GI Cancers: New Opportunities to Deliver Personalized Treatment With HER2 and Other Molecularly Targeted Therapies
Direct links:
Feb 26 2021:Manish A. Shah, MD, FASCO - Checkpoint Inhibition in Gastrointestinal Cancers: Recent Advances in Gastric, Esophageal, and Colorectal Cancers and Their Application in Clinical Practice
Direct links:
Feb 24 2021:Jacob Sands, MD - Selective Inhibition of Oncogenic Transcription and Other Novel Approaches in the Treatment of Small Cell Lung Cancer: An Illustrative Guide to Navigating the Evolving Treatment Landscape and Integrating Latest Treatment Modalities Into Clinical Care
Direct links:
Feb 22 2021:Anne H. Cross, MD, FAAN / Prof. Xavier Montalban - Exploring the Rationale, Results, and Real-World Clinical Potential of BTK Inhibitors in the Management of Multiple Sclerosis
Direct links:
Feb 19 2021:Professor Kausik Ray - Mastering the Management of Hyperlipidemia in Statin-Treated or Statin-Intolerant Patients: Recent Treatment Advances for Patients That Remain at High Risk of ASCVD
Direct links:
Feb 15 2021:Maria Arcila, MD / Zofia Piotrowska, MD - New Horizons in EGFR-Mutated NSCLC: Broadening the Impact of Precision Testing in the Context of an Expanding Treatment Landscape
Direct links:
Feb 12 2021:Mark Crowther, MD, MSc, FRCPC, FRSC - Managing Bleeding Events in Patients Receiving Direct Oral Anticoagulants: When Is It Appropriate to Implement Reversal Strategies in Patients With GI Bleeding?
Direct links:
Feb 10 2021:Maria K. Houtchens, MD, MMs - MS Treatment Decisions Before, During, and After Pregnancy: Focus on the Use of Disease-Modifying Therapies
Direct links:
Feb 3 2021:William D. Tap, MD - The Case for Challenging Conventional Care in Tenosynovial Giant Cell Tumor: Insights on Integrating Targeted Therapy Into Multimodal Management
Direct links:
Jan 29 2021:John G. Gribben, MD, DSc, FRCP, FRCPath, FMedSci - Mapping the New Era in CLL Management: Precision Medicine and Patient Perspectives in Treatment-Naïve and Relapsed Disease
Direct links:
Jan 22 2021:Steven M. Horwitz, MD - Precision Medicine in Hematologic Cancers: Lessons for Diagnostic and Treatment Protocols in CD30- and CD123-Expressing Disease
Direct links:
Jan 20 2021:Bruce Cree, MD, PhD, MAS - Provider Perspectives on Current and Emerging Disease-Modifying Treatments for Multiple Sclerosis
Direct links:
Jan 15 2021:Marcia S. Brose, MD, PhD - A Visual Exploration of New Opportunities in Thyroid Cancer: Targeting RET Alterations to Optimize Outcomes
Direct links:
Jan 13 2021:Sagar Lonial, MD, FACP / Praneetha Thulasi, MD - Targeting Ocular Toxicity in Multiple Myeloma: Opportunities for Ophthalmology-Oncology Collaboration
Direct links:
Jan 11 2021:George L. Bakris, MD - Improving Outcomes and Preventing Chronic Kidney Disease Progression: Evaluating the Role of Novel Nonsteroidal Mineralocorticoid Receptor Antagonists
Direct links:
Jan 11 2021:Ian W. Flinn, MD, PhD / Caron Jacobson, MD / Preetesh Jain, MBBS, MD, DM, PhD -Rewriting Patient Care in Mantle Cell Lymphoma: How Innovative Therapy Is Poised to Challenge Conventional Treatment
Direct links:
Jan 8 2021:Professor David I. Marks, MB, MS, FRACP, PhD, FRCPath - Exploring Antibody Therapy in ALL: How and Why to Integrate Antibody-Based Treatment Into Patient Management
Direct links:
Jan 8 2021:Nathan H. Fowler, MD - Building New Management Models for NHL Care: Tumor Board Insights on Innovative Therapeutics in FL and DLBCL
Direct links:
Jan 8 2021:Bruce R. Korf, MD, PhD - Targeting the RAS/MAPK Pathway in Neurofibromatosis Type 1 and Plexiform Neurofibromas: Improving Patient Outcomes With an Innovative Therapeutic Approach
Direct links:
Jan 8 2021:Javed Butler, MD, MPH, MBA - Making the Case for Treating Iron Deficiency in Patients With Heart Failure
Direct links:
Jan 8 2021:Sean Pokorney, MD, MBA - Improving Recognition of Nonvalvular Atrial Fibrillation to Reduce the Risk of Preventable Stroke: A Visual Guide for Clinicians
Direct links:
Jan 6 2021:Orrin Devinsky, MD - Cannabidiol in the Treatment Arsenal for Severe Epilepsy Syndromes: Practical Guidance for Managed Care Professionals
Direct links:
Jan 6 2021:Eric Gapud, MD, PhD / Michael E. Wechsler, MD - Improving Recognition and Management of EGPA: A Multidisciplinary Approach to Individualizing Treatment
Direct links:
Jan 6 2021:Robin L. Jones, MD/ Kristen Ganjoo, MD/ Emanuela Palmerini, MD, PhD - Solutions for Tenosynovial Giant Cell Tumors: Employing Effective Multimodal and Multidisciplinary Approaches to Patient Care
Direct links:
Jan 6 2021:Jarushka Naidoo, MB, BCH, MHS / Andrew Stolbach, MD, MPH - Emergency Department on Alert: Solving Oncologic Emergency Quandaries During the Immuno-Oncology Era and COVID-19 Pandemic
Direct links:
Jan 6 2021:Prof. Xavier Montalban - What’s New in Relapsing MS? Expert Perspectives on Pathogenesis, Targeting B Cells for Treatment, and Advances in Disease-State Monitoring
Direct links:
Jan 4 2021:Naval Daver, MD / Harry P. Erba, MD, PhD / Tara Lin, MD / Gail J. Roboz, MD -How I Think, How I Treat in the New Age of AML Care: Personal Perspectives on New Evidence and Innovative Therapeutics
Direct links:
Jan 4 2021:Kathleen N. Moore, MD, MS / Kristi Jhangiani, PharmD, BCPS - Managed Care Implications of the Expanding Role of PARP Inhibitors in Oncology: Evolving Evidence Base, Current Value Assessment Frameworks, and Considerations for Decision-Making in Managed Care Settings
Direct links:
Jan 4 2021:Steven Fishbane, MD - Management of Hyperkalemia in Patients With Hemodialysis-Dependent Chronic Kidney Disease: Applying New Evidence and Best Practices for Improved Patient Outcomes
Direct links:
Jan 4 2021:Amit Singal, MD, MS - Unraveling the Intricacies of HCC Management With Your Multidisciplinary Team: A Closer Look at Effective Selection and Sequencing Strategies in an Expanding Treatment Landscape
Direct links:
Dec 30 2020:Suresh S. Ramalingam, MD, FACP, FASCO - Everything You Need to Know About Molecular Testing and Targeted Therapies in NSCLC: Essential Guidance for Modern Patient-Centered Precision Lung Cancer Care
Direct links:
Dec 28 2020:Flavia Castelino, MD / Sonye K. Danoff, MD, PhD - The Evolving Treatment Landscape of SSc-ILD: Strategies to Improve Recognition and Management
Direct links:
Dec 28 2020:David F. McDermott, MD - How I Think, How I Treat: Individualizing RCC Therapy in the Era of Immuno-Oncology
Direct links:
Dec 28 2020:Richard Beaser, MD - Highlighting the Vital Role of Primary Care in Identifying and Optimizing the Treatment of Diabetic Retinopathy and Diabetic Macular Edema
Direct links:
Dec 21 2020:Victor C. Urrutia, MD, FAHA - Not So FAST: Improving the Diagnosis and Treatment of Posterior Circulation Stroke
Direct links:
Dec 21 2020:J. Fernando Arevalo, MD, PhD, FACS - Seeing the Importance of the Timely Recognition and Treatment of Diabetic Retinopathy and Diabetic Macular Edema
Direct links:
Dec 18 2020:Stephen V. Liu, MD / Bhavesh Shah, RPh, BCOP - Immunotherapy in the Treatment Arsenal for Small Cell Lung Cancer, and Managed Care Implications for the "Four Ps": Patient, Provider, Pharmacy, and Plan
Direct links:
Dec 14 2020:David R. Jones, MD - Turning Tides in Targeted Therapy for Early-Stage EGFR-Mutated NSCLC: Latest Data and Practical Guidance for Thoracic Surgeons and the Multidisciplinary Team on the Emerging Role of EGFR-Targeted Therapy in Resectable Lung Cancer
Direct links:
Dec 9 2020:Gwen A. Huitt, MD, MS - Addressing Challenges in the Treatment of Nontuberculous Mycobacterial Lung Disease: Managing Adverse Effects to Keep Patients on Therapy
Direct links:
Dec 7 2020:Roger J. Packer, MD - Progressive Pathways: Recent Recommendations and Emerging Therapies for Treating NF1-Associated Tumors
Direct links:
Dec 4 2020:George L. Bakris, MD - Show Me the Data: Improving Renal Outcomes With Glucose-Lowering Therapy in the Individualized Management of T2DM
Direct links:
Dec 2 2020:Lucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC - The Art of Medicine: Creating Treatment Regimens With GLP-1 RAs to Reduce Cardiovascular Risks in Patients With T2DM
Direct links:
Nov 30 2020:Amit Bar-Or, MD, FRCPC / Bruce Cree, MD, PhD, MAS - Realizing the Full Clinical Potential of Sphingosine-1-Phosphate Receptor Modulation to Improve Outcomes in Patients With Multiple Sclerosi
Direct links:
Nov 21 2020:Josep Tabernero, MD, PhD - Optimizing Precision Medicine in Gastric Cancer Care
Direct links:
Nov 19 2020:Peter Goadsby, MD, PhD - Addressing Unmet Needs in the Acute Treatment of Migraine: Focus on the Role of the 5-HT1F Receptor
Direct links:
Nov 18 2020:Jonathan A. Bernstein, MD - Chronic Spontaneous Urticaria From Diagnosis to Treatment: Unique Perspectives on Employing a Multidisciplinary and Patient-Centric Approach to Care
Direct links:
Nov 17 2020:Kurt Schalper, MD, PhD - Navigating the Complexities of Biomarker Testing in the Expanding Field of Precision Immuno-Oncology: Latest Evidence, Current Challenges, and Practical Guidance for Pathologists
Direct links:
Nov 13 2020:Naval Daver, MD / Joseph D. Khoury, MD, FCAP - The Pathology–Oncology Partnership in AML: Identifying and Treating the Diversity of Disease Subtypes
Direct links: